36 results
S-3
EX-4.10
NAVB
Navidea Biopharmaceuticals, Inc.
Shelf registration
28 Aug 23
5:40pm
8-K
EX-4.1
NAVB
Navidea Biopharmaceuticals, Inc.
10 Jan 23
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-4.1
rllq1icpq6du
12 Apr 22
Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE American
4:11pm
8-K
EX-4.1
y3lf08knwhc1cs
17 Jun 19
Navidea Biopharmaceuticals Announces Proposed Public Offering of Common Stock
10:00am
8-K
EX-4.1
qnf kckvn
24 Sep 13
Navidea Biopharmaceuticals Completes $30 Million Registered Direct Offering of Common Stock
12:00am
8-K
EX-4.2
y36co
26 Jun 13
Navidea Biopharmaceuticals Closes $25 Million Debt Financing with GE Capital, Healthcare Financial Services
12:00am
8-K
EX-4.1
489mhz77eqzb1twb
26 Jun 13
Navidea Biopharmaceuticals Closes $25 Million Debt Financing with GE Capital, Healthcare Financial Services
12:00am